Sharps Technology, Inc. (NasdaqCM:STSS) acquired Safegard Medical (Hungary) Kft. for $2.5 million on July 6, 2022. As reported, the consideration consists of $2.5 million in cash, plus additional consideration of 28,571 shares of Sharps Technology common stock . The purchase price of $2.5 million was released to seller at closing. The acquisition consisted primarily of Safegard's syringe manufacturing facility in Hungary and the land on which it is located, as well as certain equipment in the facility.

Sharps Technology, Inc. (NasdaqCM:STSS) completed the acquisition of Safegard Medical (Hungary) Kft. on July 6, 2022.